ALDEHYDE DERIVATIVE OF SUBSTITUTE OXAZOLIDINONES
The present invention concern towards the prodrug of 5-chloro-N-({(5S)-2-oxo-3-[4-(3- oxo-morpholin-4-yl)phenyl]-l,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, rivaroxaban per se; processes for their preparation, and the application in treatment and/or prophylaxis of diseases, especially of thr...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention concern towards the prodrug of 5-chloro-N-({(5S)-2-oxo-3-[4-(3- oxo-morpholin-4-yl)phenyl]-l,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide, rivaroxaban per se; processes for their preparation, and the application in treatment and/or prophylaxis of diseases, especially of thromboembolic disorders. The prodrug of compound formula (B) is chemically designated as5-chloro-N-formyl-N-({(5S)-2-oxo-3-[4-(3- oxomorpholin-4-yl)phenyl]- l,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide.(I)
Cette invention concerne le promédicament du 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxo-morpholin-4-yl)phényl]-l,3-oxazolidin-5-yl}méthyl)thiophène- 2-carboxamide, à savoir le rivaroxaban lui-même ; leurs procédés de préparation et leur utilisation pour traiter et/ou prévenir des maladies, notamment les troubles thromboemboliques. Le promédicament du composé de formule (B) est chimiquement désigné 5-chloro-N-formyl-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phényl]-l,3-oxazolidin-5-yl}méthyl)thiophène- 2-carboxamide.(I) |
---|